Breaking News
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
October 22, 2018 - Analyzing mouse’s potential as animal model of decision-making
October 22, 2018 - Radiotherapy can prolong survival in prostate cancer
October 22, 2018 - A genetic mutation involved in relapse
October 21, 2018 - Report reveals growing impact of cannabis on young people
October 21, 2018 - NSF awards $5 million grant to help scientists magnify societal impact of research
October 21, 2018 - Fertility Rates Down for Each Urbanization Level 2007 to 2017
October 21, 2018 - Genetically engineered 3-D human muscle transplant in a murine model
October 21, 2018 - Moms’ tight work schedules may affect their children’s sleep
October 21, 2018 - AHA: No Direct Link Between Preeclampsia and Cognitive Impairment, Study Finds
October 21, 2018 - Weight loss success linked with active self-control regions of the brain
October 21, 2018 - Scripps researchers successfully test potential new smoking-cessation treatment in rodents
October 21, 2018 - More accurate and less stressful way to measure a baby’s heartbeat
October 21, 2018 - Researchers show better cardiorespiratory fitness leads to longer life
October 21, 2018 - Healthy candies for diabetic patients
October 21, 2018 - Environment impact of microplastics remains unclear
October 21, 2018 - Antibiotics for appendicitis? Surgery often not needed
October 21, 2018 - AHA and AMA recognize more than 800 medical practices, health systems for blood pressure control
October 21, 2018 - Scientists obtain clearest ever image of Ebola virus protein
October 21, 2018 - Study reveals connection between two proteins known to be hyperactive in cancer
October 21, 2018 - Gabapentin Beats Pregabalin for Chronic Sciatica
October 21, 2018 - Cosmetic surgeons offering incomplete information for breast augmentation customers
October 21, 2018 - Chronic sleep disruption in early adult life accelerates AD-related tau pathology
October 21, 2018 - Take 10 for Mindfulness – Drugs.com MedNews
October 21, 2018 - Length of breathing disruption in OSA may be better predictor of mortality risk
October 21, 2018 - ApoE4 gene linked with chronic inflammation increases risk for Alzheimer’s disease
October 21, 2018 - Mother-daughter conflict associated with suicide risk in abused adolescent girls
October 21, 2018 - Scientists molding bacteria into unnatural shapes
October 21, 2018 - High diet quality associated with lower risk of death in colorectal cancer patients
October 21, 2018 - Discharged mental health patients ‘at greater risk of dying’
October 21, 2018 - Research provides insight into neurobiology of aggression and bullying
October 21, 2018 - As billions in tax dollars flow to private Medicaid plans, Who’s minding the store?
October 21, 2018 - Neuroscientists identify brain region that appears to be related to food preference decisions
October 21, 2018 - Deaths related to air pollution in the U.S. decreased by 47% between 1990 and 2010
Inhaled carbon dioxide triggers group of neurons responsible for arousal

Inhaled carbon dioxide triggers group of neurons responsible for arousal

image_pdfDownload PDFimage_print

Breathing too much carbon dioxide can be deadly, but it can happen during sleep if a particular sleeping position causes an obstructed airway or because of a medical condition like sleep apnea. Fortunately, inhaled carbon dioxide normally triggers sensitive brain mechanisms that prevent suffocation. Researchers have long believed that inhaled carbon dioxide activates neurons responsible for breathing and the physical effect of increased deep breathing then triggers waking from sleep (arousal).

But a new study by researchers with the Iowa Neuroscience Institute at the University of Iowa challenges that idea. The UI study identifies a group of neurons responsible for arousal that are directly triggered by carbon dioxide and cause mice to wake up without any changes to breathing. The findings were published Jan. 29 in the Journal of Neuroscience.

“Carbon dioxide-induced arousal is critical to diseases like sleep apnea and sudden infant death syndrome (SIDS), and is probably important in sudden unexpected death in epilepsy (SUDEP). However, exactly how carbon dioxide triggers waking from sleep (arousal) has not been well understood,” says Gordon Buchanan, MD, PhD, senior study author and assistant professor of neurology at the UI Carver College of Medicine. “We show that neurons that should have nothing to do with breathing cause arousal from sleep when they are directly stimulated with carbon dioxide. This represents a departure from the previous thinking and may change preventive management of these diseases where disruption of carbon dioxide-induced arousal plays a role.”

Previous research by Buchanan and his colleagues showed that serotonin (5-HT) neurons are important for carbon dioxide-induced arousal, because mice without serotonin neurons do not wake up when they inhale carbon dioxide. However, there are two major groups of serotonin neurons: one in the midbrain involved in sleep-wake regulation and one in the medulla involved in the regulation of breathing. The new study separates the effects of these two groups of serotonin neurons.

The team showed that applying carbon dioxide-enriched artificial cerebrospinal fluid directly to the serotonin neurons in mice in an area of the midbrain known as the dorsal raphe nucleus (DRN) causes arousal from sleep. This arousal was lost if these midbrain serotonin neurons were blocked either by genetic manipulation or with chemical inhibitors. Moreover, applying the carbon dioxide-enriched artificial cerebrospinal fluid directly to the serotonin neurons in the medulla increased breathing but did not cause arousal in mice.

“We propose that serotonin neurons in the DRN can be activated directly by carbon dioxide to cause waking independently of respiratory activation,” Buchanan says. “A better understanding of the mechanisms that underlie this protective reflex of waking up when too much carbon dioxide is inhaled might improve strategies for reducing death and disability caused by sleep apnea and SIDS.”

Carbon dioxide-induced arousal plays a role in both SIDS and sleep apnea, but in the case of SIDS, the arousal mechanism is thought to be impaired, while in the sleep apnea the arousal mechanism works well, but that leads to a host of secondary health problems.

Babies that are susceptible to SIDS are not awakened by increased carbon dioxide when airway obstruction occurs. This might happen if the baby is sleeping face down, or their nose and mouth are covered by soft bedding, a plush toy, or a co-sleeping parent. In contrast, carbon-dioxide-induced arousal causes people with sleep apnea to awake frequently – in many cases hundreds of times during a night. This sleep disruption is associated with significant health problems, including poor cognitive function, excessive sleepiness, and cardiovascular and metabolic complications.

“While our findings are far from ready for clinical application, this work suggests that there should be ways to prevent apnea by maintaining normal carbon dioxide during sleep without causing arousal or to augment the arousal mechanisms in babies thought to be at higher risk for SIDS. Similar approaches might also help prevent SUDEP,” Buchanan says.

Source:

https://medicine.uiowa.edu/content/specific-neurons-trigger-waking-due-inhaled-co2

Tagged with:

About author

Related Articles